Key Trials for Pharmacists to Know in Prostate Cancer Research

Article

Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut discusses key trials in prostate cancer research.

Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut discusses key trials in prostate cancer research.

Transcript

Over the last year and a half or so, there have been 2 drugs that have been evaluated in the treatment of non-metastatic castration-resistant prostate cancer. There’s actually a third one that data was just presented recently. The drugs are apalutamide and enzalutamide, that I talked about during the discussion, and the third drug is darolutamide, that the information was published on the phase 3 trial in the New England Journal of Medicine just this month.

So both trials looking at evaluating apalutamide and enzalutamide were phase 3 randomized controlled trials comparing against placebo because that was really standard of care was given androgen deprivation therapy alone in those patients. And they were looking to determine whether or not the addition of apalutamide to androgen deprivation therapy or enzalutamide would prolong the time to the development of metastases, so the metastasis-free survival time. And both of those trials showed a statistically significant improvement of about 2 years in terms of adding on this additional anti-androgen therapy and with overall tolerability, and I think that will change how we treat this population of prostate cancer patients. And the implications for pharmacists are that we now need to learn about a new anti-androgen. Apalutamide was not on the marker prior to the results of this study, and how we might use enzalutamide in this different population. So there’s learning the drug interactions, how to counsel patients on the drugs, what side effects to monitor for are really going to be key areas for pharmacists to become involved in.

Related Videos
pain management palliative care/Image Credits: © Aleksej - stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
palliative and hospice care/ Image Credits: © David Pereiras - stock.adobe.com
cancer pain management | Image Credits: © Burlingham - stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit:  appledesign | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.